Skip to main content

CON-TGO91-257 - Novartis Pharmaceuticals Australia Pty Ltd

Product names
  • AUST R 93165 - DIOVAN valsartan 40mg film-coated tablet blister pack
  • AUST R 80868 - DIOVAN valsartan 80mg film-coated tablet blister pack
  • AUST R 80871 - DIOVAN valsartan 160mg film-coated tablet blister pack
  • AUST R 123357 - DIOVAN valsartan 320 mg film-coated tablet blister pack
Decision Date
Duration
The consent is effective for all batches manufactured between 1 September 2020 and 31 August 2021.
Non-compliance with standard

The product(s) do not conform with the requirements of TGO 91 but are supplied with label(s) that have been approved by the TGA.

Supply/Import or Export
Supply
Therapeutic good type
Prescription medicines

Help us improve the Therapeutic Goods Administration site